Japan
· Delayed Price · Currency is JPY Chordia Therapeutics Statistics
Total Valuation
TYO:190A has a market cap or net worth of JPY 14.97 billion. The enterprise value is 11.69 billion.
| Market Cap | 14.97B |
| Enterprise Value | 11.69B |
Important Dates
The next estimated earnings date is Monday, July 14, 2025.
| Earnings Date | Jul 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TYO:190A has 68.99 million shares outstanding.
| Current Share Class | 68.99M |
| Shares Outstanding | 68.99M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.68% |
| Owned by Insiders (%) | 3.31% |
| Owned by Institutions (%) | 21.83% |
| Float | 25.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 4.61 |
| P/TBV Ratio | 4.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.84 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.85 |
Financial Position
The company has a current ratio of 16.72
| Current Ratio | 16.72 |
| Quick Ratio | 15.98 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -61.24% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -86.99M |
| Employee Count | 23 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TYO:190A has paid 2.42 million in taxes.
| Income Tax | 2.42M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.13% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -24.13% |
| 50-Day Moving Average | 221.56 |
| 200-Day Moving Average | 258.37 |
| Relative Strength Index (RSI) | 51.68 |
| Average Volume (20 Days) | 738,970 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.99B |
| Pretax Income | -2.00B |
| Net Income | -2.00B |
| EBITDA | -1.98B |
| EBIT | -1.99B |
| Earnings Per Share (EPS) | -30.96 |
Balance Sheet
The company has 3.28 billion in cash and n/a in debt, giving a net cash position of 3.28 billion or 47.49 per share.
| Cash & Cash Equivalents | 3.28B |
| Total Debt | n/a |
| Net Cash | 3.28B |
| Net Cash Per Share | 47.49 |
| Equity (Book Value) | 3.25B |
| Book Value Per Share | 47.06 |
| Working Capital | 3.22B |
Cash Flow
In the last 12 months, operating cash flow was -2.00 billion and capital expenditures -1.03 million, giving a free cash flow of -2.00 billion.
| Operating Cash Flow | -2.00B |
| Capital Expenditures | -1.03M |
| Free Cash Flow | -2.00B |
| FCF Per Share | -28.99 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TYO:190A does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -13.37% |
| FCF Yield | -13.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |